(Q41127960)

27 September 2017

1 reference

title

The management of treatment-resistant depression in the medically ill. (English)

1 reference

treatment-resistant depression

27 September 2017

1 reference

Franco-Bronson K

1

1 reference

27 September 2017

1 June 1996

1 reference

Psychiatric Clinics of North America

27 September 2017

1 reference

27 September 2017

19

1 reference

27 September 2017

2

1 reference

27 September 2017

329-350

1 reference

Is unilateral electroconvulsive therapy really the treatment of choice in endogenous depression?

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Interactions of moclobemide with concomitantly administered medication: evidence from pharmacological and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Hepatic disease and psychiatric illness: relationships and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Moclobemide and Tricyclic Antidepressants in Severe Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Use of psychotropic drugs in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Elevation of immunoreactive CSF TRH in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Increased TSH response to TRH in refractory depressed women

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Neuroendocrinological investigations during sleep deprivation in depression. I. Early morning levels of thyrotropin, TH, cortisol, prolactin, LH, FSH, estradiol, and testosterone.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Fluoxetine and extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Pemoline. An alternative psychostimulant for the management of depressive disorders in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

New Pharmacological Approaches to Therapy of NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Neuropsychiatric consequences of renal failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Reduction of distress in hyperprolactinemia with bromocriptine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Dextroamphetamine treatment for depression in terminally ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Ventricular tachycardia and psychiatric depression in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Bromocriptine for prolactinoma-related dissociative disorder and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Hepatotoxicity of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

A meta-analysis of the efficacy of cognitive therapy for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

National Institute of Mental Health Treatment of Depression Collaborative Research Program

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

The behavioral toxicity of reversible inhibitors of monoamine oxidase A: laboratory and clinical investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Bupropion in Tricyclic Antidepressant Nonresponders with Unipolar Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Cognitive impairment due to AIDS-related complex and its response to psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Appetite and food preference in depression: effects of imipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Depression following myocardial infarction. Impact on 6-month survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Failure of T3 to potentiate tricyclic antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Bupropion in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Major depressive disorder in patients with the implantable cardioverter defibrillator. Two cases treated with ECT

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

The clinical meaning of refractory depression: a review for the clinician

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Unrecognized physical illness prompting psychiatric admission: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Acetazolamide in bipolar affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Selegiline and cognitive function in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Moclobemide safety: monitoring a newly developed product in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Tamoxifen-associated reduction in tricyclic antidepressant levels in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Parkinsonism exacerbated by paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Methylphenidate in stroke patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Use of imipramine in diabetics. Effects on glycosuria and blood sugar levels

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Adequacy and duration of antidepressant treatment in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Use of psychostimulants in medically ill depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Use of tricyclic antidepressants in recipients of heart transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Treatment of depression in Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Interpersonal psychotherapy (IPT) and drugs in the treatment of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Acidophilus for sertraline-induced diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Effect of bromocriptine on affect and libido in hyperprolactinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Moclobemide Versus Clomipramine in Depressed Patients in General Practice. A Randomized, Double-Blind, Parallel, Multicenter Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Learned helplessness in diabetic youths.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Desipramine in treatment of Parkinson's disease. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Depression and the reporting of diabetes symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Treatment resistant depression: a clinical perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Shuttle-box deficits induced by inescapable shocks in rats: reversal by the beta-adrenoreceptor stimulants clenbuterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Helpless behavior (escape deficits) in streptozotocin-diabetic rats: resistance to antidepressant drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

The relationship of serotonin to depression in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Combination of fluoxetine with pemoline in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Desipramine treatment of major depression in patients over 75 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Recent clinical development with reversible and selective amine oxidase inhibitors: a valuable addition to the armamentarium. Chairman's introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Approaches to the Evaluation and Treatment of Rapid-Cycling Affective Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Fluoxetine: a serotonin-specific, second-generation antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Group support for patients with metastatic cancer. A randomized outcome study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Serotonin syndrome caused by a moclobemide-clomipramine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

ECT in a patient with a frontal craniotomy and residual meningioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Thyroid hormones in the treatment of affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Long-term methylphenidate use in the medically ill patient with organic mood syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Expanding psychopharmacologic treatment options for the depressed medical patient

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

How can care for depression become more cost-effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Decreasedβ- Adrenergic Receptors in Rat Heart in Streptozotocin-Induced Diabetes: Role of Thyroid Hormones*

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

High-dose selegiline in treatment-resistant older depressive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Psychiatric aspects of liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Compensatory pituitary-thyroid mechanisms in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Psychopharmacologic issues in organ transplantation. Part 2: Psychopharmacologic medications

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Psychopharmacologic issues in organ transplantation. Part I: Pharmacokinetics in organ failure and psychiatric aspects of immunosuppressants and anti-infectious agents

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Psychopharmacology and neuropsychiatric syndromes in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

The spectrum of thyroid disease in a community: the Whickham survey

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Depression masquerading as diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Psychostimulants in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Psychosocial intervention with cancer patients: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

The existential plight in cancer: significance of the first 100 days

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

A potential clinical use for methylphenidate with tricyclic antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970291-4

7 January 2021

10.1016/S0193-953X(05)70291-4

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8827193